Similar articles

• Hydroxyurea and sickle cell disease: a chance for every patient.

  Weiner DL, Brugnara C. Weiner DL, et al. JAMA. 2003 Apr 2;289(13):1692-4. doi: 10.1001/jama.289.13.1692. JAMA. 2003. PMID: 12672739 No abstract available.
• Hydroxyurea for sickle cell anemia.

  Naina HV, Harris S. Naina HV, et al. N Engl J Med. 2008 Jul 3;359(1):98; author reply 98-9. doi: 10.1056/NEJMc080902. N Engl J Med. 2008. PMID: 18596283 No abstract available.
• Hydroxycarbamide for sickle-cell anaemia in infancy.

  Weatherall DJ. Weatherall DJ. Lancet. 2011 May 14;377(9778):1628-30. doi: 10.1016/S0140-6736(11)60511-4. Lancet. 2011. PMID: 21571132 No abstract available.
• [From Hemoglobin SS to SF: interest of hydroxyurea in the management of sickle cell disease in two Congolese children and review of the literature].

  Nkashama GM, Wakamb GK, Mulangu AM, Nkashama GM, Kupa BK, Numbi OL. Nkashama GM, et al. Pan Afr Med J. 2015 Jun 15;21:124. doi: 10.11604/pamj.2015.21.124.5784. eCollection 2015. Pan Afr Med J. 2015. PMID: 26327961 Free PMC article. Review. French.
• Novel approaches to the treatment of sickle cell disease: the potential of histone deacetylase inhibitors.

  Okam MM, Ebert BL. Okam MM, et al. Expert Rev Hematol. 2012 Jun;5(3):303-11. doi: 10.1586/ehm.12.20. Expert Rev Hematol. 2012. PMID: 22780210 Review.